US2017319604A1
|
|
Thyroid hormone receptor agonist and use thereof
|
WO2011038207A1
|
|
Phosphorus-containing thyroid hormone receptor agonists and methods of use
|
EP2805951A2
|
|
Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof
|
WO2010093601A1
|
|
Novel sulfonic acid-containing thyromimetics, and methods for their use
|
CN102292316B
|
|
Glucagon antagonists
|
TW200936146A
|
|
Antiviral nucleoside compounds
|
MX2010001784A
|
|
Novel activators of glucokinase.
|
WO2009012039A2
|
|
Crystalline polymorphs
|
CN105566265A
|
|
Antagonists of the glucagon receptor
|
WO2008019309A1
|
|
Novel inhibitors of fructose 1,6-bisphosphatase
|
WO2007081755A2
|
|
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
AU2006202624A1
|
|
Novel bisamidate phosphonate prodrugs
|
CN101189248A
|
|
Novel phosphorus-containing thyromimetics
|
US2009232879A1
|
|
Thyromimetics for the Treatment of Fatty Liver Diseases
|
AU2006249348A1
|
|
Novel phosphinic acid-containing thyromimetics
|
CN101180097A
|
|
Novel phosphinic acid-containing thyromimetics
|
US2008070867A1
|
|
2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases
|
AU2005227362A1
|
|
Novel aryl fructose-1, 6-bisphosphatase inhibitors
|
EP1841749A1
|
|
Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
|
EP1778250A2
|
|
Novel thiazole inhibitors of fructose 1,6-bisphosphatase
|